Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients

BACKGROUND: Switching antiretroviral therapy (ART) in people with HIV (PWH) can influence their risk for drug–drug interactions (DDIs). The purpose of this study was to assess changes in the incidence and severity of DDIs among PWH who switched their ART to bictegravir/emtricitabine/tenofovir alafen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Schafer, Jason J, Pandit, Neha S, Cha, Agnes, Huesgen, Emily, Badowski, Melissa, Sherman, Elizabeth M, Cocohoba, Jennifer, Shimada, Ayako, Keith, Scott W
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Major Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813207/
https://ncbi.nlm.nih.gov/pubmed/33511239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa625
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi